Feasibility and Efficacy of Time-Restricted Eating in Diabetes Management
This is a randomized clinical trial to assess the feasibility and efficacy of time-restricted eating (TRE) to improve glucose regulation and cardiovascular health of participants with type 2 diabetes mellitus (T2DM). Participants will be randomized into 2 groups: 1) standard of care (SOC), in which they will continue to follow their physician's treatment plan, or 2) SOC and TRE (8-10 hours eating window).
• Age: 18-75 years old
• Patients with T2DM with A1c between 6.5 and 9.0 % and on stable doses of medications who are weight-bearing and self-ambulatory.
• Own a smartphone (Apple iOS or Android OS)
• Baseline eating period ≥12 hours/day and sufficient logging on the mCC app.
• Women of childbearing age will be given a pregnancy test on study enrollment and asked to use contraception throughout the study.
• Post-menopausal and women on hormone replacement therapy will be included.
• Estimated Glomerular Filtration Rate (EGFR) \> 30mL/min/1.73m2
• If participants are on cardiovascular medications (HMG CoA reductase inhibitors (statins), other lipid-modifying drugs, anti-hypertensives) no dose adjustments will be allowed during the study period
• Patients on stable doses of GLP-1 receptor agonists will be included.